Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 76,012	$ 37,215	$ 137,821	$ 271,952
Operating expenses:
Direct cost of revenue	15,503	18,356	26,528	168,419
Professional fees (includes related party amounts of $155,000 $90,000, $422,000, and $270,000 respectively)	303,574	460,378	1,721,479	1,445,004
Salary expenses	330,221	517,192	2,147,967	2,084,430
Research and development	708,220	241,748	3,297,986	877,936
Stock-based compensation	271,517	64,074	1,664,191	626,449
Depreciation and amortization	210,361	1,425	631,083	5,849
Other general and administrative expenses	469,656	489,820	1,478,726	944,248
Total operating expenses	2,309,052	1,792,993	10,967,960	6,152,335
Total operating loss	(2,233,040)	(1,755,778)	(10,830,139)	(5,880,383)
Other income (expense)
Interest and accretion expenses	(810,598)	(70,221)	(1,640,368)	(74,410)
Change in fair value of contingent liabilities	1,491,000	194,000	(2,131,000)	472,000
Total other income (expense)	680,402	123,779	(3,771,368)	397,590
Net loss	$ (1,552,638)	$ (1,631,999)	$ (14,601,507)	$ (5,482,793)
Loss per share – basic and diluted	$ (0.04)	$ (0.05)	$ (0.36)	$ (0.15)
Weighted average number of shares of common stock outstanding – basic and diluted	40,828,188	35,928,188	40,762,254	35,928,188